港股维升药业-B(02561)尾盘涨超4%，截至发稿涨4.05%，报34.98港元，成交额96.64万港元。11月6日第八届进博会期间，维升药业达成多项合作，与东富龙达成双腔冻干制剂技术战略合作，还与临港新片区管委会等签署产业协同协议，推动“全球创新、中国加速”战略进一步落地。此外，维升药业今年首次以参展商身份亮相进博会，携两款全球创新药物登场，包括全球首个且唯一用于治疗成人慢性甲状旁腺功能减退症...
Source Link港股维升药业-B(02561)尾盘涨超4%，截至发稿涨4.05%，报34.98港元，成交额96.64万港元。11月6日第八届进博会期间，维升药业达成多项合作，与东富龙达成双腔冻干制剂技术战略合作，还与临港新片区管委会等签署产业协同协议，推动“全球创新、中国加速”战略进一步落地。此外，维升药业今年首次以参展商身份亮相进博会，携两款全球创新药物登场，包括全球首个且唯一用于治疗成人慢性甲状旁腺功能减退症...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.